Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Lang

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
Laryngo- Rhino- Otologie|March 24, 2021
[Hereditary hemorrhagic telangiectasia: symptoms and diagnostic latency]Freya Droege, Cornelius H L Kuerten, Christina Kaiser, et al.
Frontiers in Oncology|May 31, 2021
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabMichael Pogorzelski, Thomas Hilser, Saskia C Ting, et al.
Cancers|September 9, 2023
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung MetastasesKonstantinos Grapatsas, Fabian Dörr, Hruy Menghesha, et al.
Stem Cell Research & Therapy|August 14, 2014
The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancerBenjamin A Kansy, Philip A Dißmann, Hatim Hemeda, et al.
International Journal of Cancer|November 9, 2021
SIRT1-mediated deacetylation of FOXO3a transcription factor supports pro-angiogenic activity of interferon-deficient tumor-associated neutrophilsSharareh Bordbari, Britta Mörchen, Ekaterina Pylaeva, et al.
Oncoimmunology|November 1, 2018
T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic responseBenjamin A Kansy, Gulidanna Shayan, Hyun-Bae Jie, et al.
Cancers|July 2, 2021
B-Helper Neutrophils in Regional Lymph Nodes Correlate with Improved Prognosis in Patients with Head and Neck CancerEkaterina Pylaeva, Irem Ozel, Anthony Squire, et al.
Laryngo- Rhino- Otologie|June 2, 2023
[Recommendations of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) for the granting of resident training program authorizations]Orlando Guntinas-Lichius, Stephan Lang, Timo Stöver, et al.
Frontiers in Oncology|July 10, 2025
Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomesCornelius H L Kürten, Vinithagowry Sivakumar, Sebastian Waßenberg, et al.
Journal of Extracellular Biology|June 8, 2026
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient PlasmaTobias Tertel, Fabiola Nardi Bauer, Oumaima Stambouli, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Laryngo- Rhino- Otologie|March 24, 2021
[Hereditary hemorrhagic telangiectasia: symptoms and diagnostic latency]Freya Droege, Cornelius H L Kuerten, Christina Kaiser, et al.
Frontiers in Oncology|May 31, 2021
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabMichael Pogorzelski, Thomas Hilser, Saskia C Ting, et al.
Cancers|September 9, 2023
New Prognostic Score (Essen Score) to Predict Postoperative Morbidity after Resection of Lung MetastasesKonstantinos Grapatsas, Fabian Dörr, Hruy Menghesha, et al.
Stem Cell Research & Therapy|August 14, 2014
The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancerBenjamin A Kansy, Philip A Dißmann, Hatim Hemeda, et al.
International Journal of Cancer|November 9, 2021
SIRT1-mediated deacetylation of FOXO3a transcription factor supports pro-angiogenic activity of interferon-deficient tumor-associated neutrophilsSharareh Bordbari, Britta Mörchen, Ekaterina Pylaeva, et al.
Oncoimmunology|November 1, 2018
T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic responseBenjamin A Kansy, Gulidanna Shayan, Hyun-Bae Jie, et al.
Cancers|July 2, 2021
B-Helper Neutrophils in Regional Lymph Nodes Correlate with Improved Prognosis in Patients with Head and Neck CancerEkaterina Pylaeva, Irem Ozel, Anthony Squire, et al.
Laryngo- Rhino- Otologie|June 2, 2023
[Recommendations of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) for the granting of resident training program authorizations]Orlando Guntinas-Lichius, Stephan Lang, Timo Stöver, et al.
Frontiers in Oncology|July 10, 2025
Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomesCornelius H L Kürten, Vinithagowry Sivakumar, Sebastian Waßenberg, et al.
Journal of Extracellular Biology|June 8, 2026
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient PlasmaTobias Tertel, Fabiola Nardi Bauer, Oumaima Stambouli, et al.
Pageof 23